Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 Pandemic and Biological Therapy in Rheumatologic Disorders: How to Deal With? Publisher Pubmed



Ahmadinejad Z1, 2 ; Assari R3 ; Ayoobi Yazdi N2, 4 ; Mazloomi SH2 ; Javanshayani P2 ; Khalili Afousi H5 ; Ziaee V3, 6, 7
Authors

Source: Reumatismo Published:2020


Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has involved more than 159 countries and more than 5 million people worldwide. A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted with chief complaints of fever, chills, malaise, myalgia, and dyspnea. Chest computed tomography showed bilateral subsegmental atelectasis and diffuse ground-glass opacities in both lungs inducing the suspicion of COVID-19 infection. The oro-nasopharynx swab sample for COVID-19 polymerase chain reaction was positive. In addition to supportive care, lopinavir/ritonavir 400/100 mg twice daily and oseltamivir (75 mg) twice daily were started in combination with a starting dose of hydroxychloroquine (400 mg). The methotrexate dose was decreased, and the dose of prednisolone was increased to 30 mg for 10 days. Azathioprine and adalimumab were continued at previous doses. The use of biologic agents and DMARDs in rheumatic patients is a serious challenge in the COVID-19 pandemic. In conclusion, during the COVID-19 pandemic, due to the key roles of cytokines in the promotion of the disease, the rheumatic patients may benefit from continuing their previous treatment, which may have protective effects. © 2020, Page Press Publications. All rights reserved.
Other Related Docs
9. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
10. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
14. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)
15. A Case of Multiple Large Left Ventricular Clots in a Patient With Covid-19, International Cardiovascular Research Journal (2021)
20. Histopathologic Changes and Cellular Events of Organs Systems in Covid-19, Journal of Cellular and Molecular Anesthesia (2021)